Global Flea, Tick, and Heartworm Products Market Poised to Grow Substantially by 2024

 

Global Flea Tick and Heartworm Products Market
global flea, tick, and heartworm products market



The global flea, tick, and heartworm products market includes a wide range of products that are used to treat infestations caused by fleas, ticks, and prevent diseases transmitted by them in pets. Flea, tick, and heartworm products include spot-on/topical products, oral pills, collars, shampoos and sprays. These products prevent fleas, ticks from biting pets and also prevent diseases like lyme disease, rocky mountain spotted fever, etc. Caring for pets health and well-being has become a top priority for many pet owners globally which is driving demand for such preventive products. Advancements in product formulations have improved efficacy and administration convenience. The global flea, tick, and heartworm products market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031.


Key Takeaways

Key players operating in the global flea, tick, and heartworm products market are Zoetis, Promika, LLC, Sergeant’s Pet Care Products, Inc., Adams, Merck and Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Inc., Elanco, Ceva, and The Hartz Mountain Corporation. These leaders are investing heavily in R&D to develop novel formulations and focus on portfolio expansion through acquisitions.

The Global Flea, Tick, and Heartworm Products Market Demand is witnessing several opportunities such as development of combination products to treat multiple infestations, innovations to improve product effectiveness and suitability for multiple pet types. Companies are also focusing on expanding to untapped markets in Asia Pacific, Latin America, Middle East and Africa through partnerships and distribution agreements.

Global expansion remains a key focus for leading players. Several companies have enhanced their international footprint through acquisitions of regional players in recent years. For instance, Elanco acquired Bayer’s animal health business in 2020 to expand its presence in Latin America and Europe. Similarly, Boehringer Ingelheim concluded an acquisition of Merck Animal Health’s Genesis operation in 2021 to strengthen operations in China.

Market Drivers

Growing pet population and rising pet ownership especially in developing nations is a key factor fueling demand for flea, tick and heartworm preventive products. According to the American Pet Products Association, the U.S pet industry was valued at $99 billion in 2020 and pet ownership grew by a robust 5.6% during the COVID pandemic.

Increasing awareness about pet healthcare management and vector-borne pet diseases also drives the need for protective medications. Organizations like Companion Animal Parasite Council (CAPC) create awareness among pet owners and veterinarians about importance of prevention and earmark ‘Seresto’ collars for tick and flea control. This fuels adoption of long-lasting collars.

Market Restrains

High treatment costs associated with some of the premium products poses affordability challenges in some markets. This has resulted in higher demand for generic flea, tick, and heartworm products in developing nations.

Strict regulatory framework for approval and marketing of veterinary drugs also acts as a barrier, delaying product launches. However, efforts towards harmonization of guidelines by organizations like VICH aims to address these challenges over the long term.

Segment Analysis

The global flea, tick, and heartworm products market is dominated by the tick treatment sub segment owing to the rising prevalence of tick-borne illnesses globally. The increasing cases of Lyme disease and Rocky Mountain spotted fever has led to a surge in demand for tick control products. The easy availability and effectiveness of tick collars and spot-on has further contributed to the growth of this sub segment. The heartworm preventatives sub segment holds the second largest market share due to rising pet adoption and greater awareness about heartworm disease among pet owners.

Regional Analysis

North America dominates the global market and accounted for the largest revenue share in 2024 owing to high pet healthcare expenditure, wide availability of innovative products and existence of major industry players in the region. However, Asia Pacific flea, tick, and heartworm products market is expected to witness the highest growth during the forecast period supported by increasing pet population, rising disposable income and growing awareness about zoonotic diseases in countries such as China, India and Japan. Latin America and Middle East & Africa also offer lucrative opportunities for market expansion due to burgeoning pet care industry and investments by international brands. Europe will continue to be another prominent regional market during the study period.


Gets More Insights on: Global Flea, Tick, and Heartworm Products Market

Comments

Post a Comment

Popular posts from this blog

Positively Precise: Navigating the Veterinary Blood Glucose Market

Image
  Veterinary Blood Glucose Market In the realm of veterinary care, precision is paramount, especially when it comes to monitoring blood glucose levels in our furry companions. Just like humans, pets can suffer from diabetes, a condition that requires careful management and monitoring. As a result, the veterinary blood glucose market has seen significant growth and demand in recent years, driven by the increasing awareness of pet health and advancements in technology. The veterinary blood glucose monitoring devices market size is expected to reach US$ 874.5 million by 2030, from US$ 460.3 million in 2023, at a CAGR of 9.6% during the forecast period. Market Growth and Demand The veterinary blood glucose market has witnessed steady growth, fueled by a rising pet population and an increasing awareness of diabetes in animals. According to recent studies, the prevalence of diabetes in pets, particularly in cats and dogs, has been on the rise. This has led to a surge in demand f...
Read more

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is Anticipated to Witness High Growth Owing to Rising Adoption of Outsourcing Strategies by Pharma Companies

Image
  Global Pharmaceutical Contract Sales Outsourcing Market The global pharmaceutical contract sales outsourcing (CSO) market involves sales and marketing outsourcing services provided by contract sales organizations to pharmaceutical companies. CSOs help pharmaceutical companies in promoting their drugs to healthcare professionals through their field sales teams. The services provided include sales force optimization, mapping physician networks, data analytics for sales force effectiveness, and ensuring product availability through distribution channels. The pharmaceutical CSO market is driven by the need to optimize sales and marketing costs for pharmaceutical companies. Outsourcing non-core sales and marketing functions allows pharma companies to focus on drug research and development. The global pharmaceutical CSO market is estimated to be valued at US$ 8,599.2 Mn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031. Key Takeaways Key pl...
Read more

The Cancer Drugs Market Is Trends Towards Precision Medicine

Image
   Cancer Drugs Market The cancer drugs market comprises of pharmaceuticals that are used in the treatment of various types of cancers. These drugs are usually classified into chemotherapy drugs, targeted drugs, immunotherapy drugs and others. Chemotherapy drugs work by slowing or stopping the growth of cancer cells through chemical or biological means. Targeted drugs attack specific cancer cells by blocking their growth and spread. Immunotherapy drugs help boost the body's natural defenses to fight cancer. The global cancer drugs market is estimated to be valued at US$ 177.87 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the cancer drugs market are U.S. Silica Holdings Inc., Sibelco Group, Fairmount Santrol Holdings Inc., Emerge Energy Services LP, Badger Mining Corporation, Covia Holdings Corporation, Preferred Sands LLC, Hi-Crush Partners LP, SCR-Sibelco N.V., Pattison Sand Company. T...
Read more